Skip to Main Content

Paper Details

Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial.
Ann Intensive Care
30
2019
Author NameAffiliation
Kealy R HamRegions Hospital, University of Minnesota
William W BusseEmory University
Michelle N GongAlbert Einstein College of Medicine
Ashish K KhannaWake Forest School of Medicine
Lakhmir S ChawlaLa Jolla Pharmaceutical Company
George F TidmarshLa Jolla Pharmaceutical Company
Marlies OstermannGuy's and St. Thomas Hospital, King's College London
  • 1 - 7

Datasets

Release 1.2